Candel Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
Go back to Candel Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights| (NASDAQ: CADL) | Delayed: 10.36 +0.57 (5.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.79 | 52 Week High | $ | |||
| Open | $9.88 | 52 Week Low | $ | |||
| Day High | $10.38 | P/E | N/A | |||
| Day Low | $9.80 | EPS | $ | |||
| Volume | 1,481,738 | |||||

